Skip to content

Aranidipine

Drug profile

Also known as: sapresta

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Aranidipine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including CACNA1D|CACNA1C. Recorded indications include Hypertensive disorder.

  • Molecular targets: CACNA1D|CACNA1C (1 listed in DrugCentral).
  • Indications: Hypertensive disorder.
  • Molecular formula: C19H20N2O7; molecular weight 388.38 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Hypertensive disorder

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
Voltage-gated L-type calcium channelCACNA1D|CACNA1Cblocker—

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Aranidipine is on its molecule page.

Molecular formulaC19H20N2O7
Molecular weight388.38 g/mol
CAS number86780-90-7
InChIKeyNCUCGYYHUFIYNU-UHFFFAOYSA-N
PubChem CID2225
COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Aranidipine used for?

DrugCentral lists the following indications for Aranidipine: Hypertensive disorder.

How does Aranidipine work?

Its molecular targets in DrugCentral include CACNA1D|CACNA1C (blocker).

What is the chemical formula of Aranidipine?

Aranidipine has the molecular formula C19H20N2O7 and a molecular weight of 388.38 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets1
Indications1
FormulaC19H20N2O7
DrugCentral ID234
Interactive profile